Isabelle Arnulf Selected Research

Restless Legs Syndrome (Restless Legs)

7/2013	Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
6/2010	Case scenario: anesthetic implications of restless legs syndrome.
4/2009	Dopamine dysregulation syndrome in a patient with restless legs syndrome.
5/2005	Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Arnulf Research Topics

Disease

34	Narcolepsy 10/2023 - 11/2004
20	Cataplexy 01/2023 - 11/2004
19	Disorders of Excessive Somnolence (Hypersomnia) 11/2023 - 11/2004
18	Sleepiness 11/2023 - 06/2005
17	Parkinson Disease (Parkinson's Disease) 08/2023 - 08/2008
12	Idiopathic Hypersomnia 10/2023 - 09/2009
10	REM Sleep Behavior Disorder 09/2022 - 05/2011
9	Parkinsonian Disorders (Parkinsonism) 01/2023 - 12/2009
8	Sleep Wake Disorders 11/2023 - 08/2006
7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2015 - 12/2004
5	Synucleinopathies 01/2022 - 04/2016
5	Dementia (Dementias) 01/2022 - 05/2012
5	Kleine-Levin Syndrome (Syndrome, Kleine-Levin) 01/2022 - 08/2015
5	Hallucinations (Hallucination) 10/2019 - 06/2009
4	Parasomnias (Parasomnia) 09/2022 - 06/2007
4	Obstructive Sleep Apnea 01/2019 - 03/2011
4	Restless Legs Syndrome (Restless Legs) 07/2013 - 05/2005
3	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2023 - 10/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2020
3	Sleep Deprivation 01/2021 - 11/2002
3	Somnambulism (Sleepwalking) 01/2021 - 10/2009
3	Sleep Paralysis 10/2019 - 06/2009
2	Dystonia (Limb Dystonia) 08/2023 - 03/2010
2	Cognitive Dysfunction 01/2022 - 10/2015
2	Fatigue 01/2021 - 06/2009
2	Apnea 01/2021 - 11/2011
2	Obesity 01/2021 - 01/2013
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2021 - 12/2014
2	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2018 - 01/2017
2	Multiple System Atrophy 01/2017 - 03/2011
2	Human Influenza (Influenza) 01/2015 - 08/2013
1	Hyperhidrosis 01/2024
1	Autoimmune Diseases of the Nervous System 11/2023
1	Craniopharyngioma (Craniopharyngiomas) 10/2023
1	Disease Susceptibility (Diathesis) 04/2023
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2023
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023
1	Dizziness (Lightheadedness) 01/2022
1	Atrophy 01/2022
1	Hypercapnia 01/2021
1	Obesity Hypoventilation Syndrome (Pickwickian Syndrome) 01/2021
1	Night Terrors (Sleep Terror) 12/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Spontaneous Abortion (Miscarriage) 10/2019

Drug/Important Bio-Agent (IBA)

16	OrexinsIBA 01/2023 - 08/2006
12	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 10/2023 - 11/2004
9	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 11/2023 - 06/2009
8	neuromelaninIBA 01/2023 - 07/2013
8	Modafinil (Provigil)FDA Link 01/2023 - 06/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
6	pitolisantIBA 01/2021 - 04/2008
5	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 08/2005
5	IronIBA 11/2021 - 12/2004
5	Histamine (Histamine Dihydrochloride)FDA Link 10/2019 - 04/2008
5	HLA-DQB1 antigen (HLA DQB1)IBA 08/2016 - 08/2006
5	Levodopa (L Dopa)FDA LinkGeneric 07/2014 - 08/2005
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 02/2007
4	MelatoninIBA 01/2016 - 11/2002
4	Methylphenidate (Ritalin)FDA LinkGeneric 06/2014 - 05/2005
4	Dopamine Agonists (Dopamine Agonist)IBA 07/2013 - 05/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 09/2010
3	Clonazepam (Rivotril)FDA LinkGeneric 05/2015 - 06/2007
3	Mazindol (Mazanor)FDA Link 06/2014 - 03/2012
3	ropinirole (Requip)FDA LinkGeneric 08/2008 - 05/2005
3	Ferritins (Ferritin)IBA 01/2008 - 12/2004
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2024 - 01/2021
2	Apomorphine FDA Link 08/2023 - 01/2022
2	alpha-SynucleinIBA 09/2022 - 01/2022
2	SynucleinsIBA 01/2022 - 11/2014
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 07/2014
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2021
2	CytokinesIBA 08/2015 - 06/2015
2	VaccinesIBA 06/2015 - 08/2013
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 06/2014 - 03/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 11/2013 - 01/2013
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 11/2013 - 03/2012
2	Glucose (Dextrose)FDA LinkGeneric 10/2013 - 10/2007
2	Dopamine Agents (Dopaminergic Agents)IBA 12/2009 - 08/2005
1	oxybutynin (Tavor)FDA LinkGeneric 01/2024
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2024
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 11/2023
1	Amino Acids FDA Link 04/2023
1	Orexin ReceptorsIBA 01/2023
1	Coffee FDA Link 01/2022
1	PrionsIBA 01/2022
1	SolutionsIBA 01/2022
1	Muscarinic AntagonistsIBA 01/2021
1	Carbon DioxideIBA 01/2021
1	tropatepineIBA 01/2021
1	SilverIBA 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2022 - 06/2007
3	Continuous Positive Airway Pressure 01/2018 - 06/2007
2	Precision Medicine 09/2022 - 09/2019
2	Compression Stockings 11/2011 - 03/2011
1	Radiotherapy 10/2023
1	Bed Rest (Bedrest) 10/2023
1	Transjugular Intrahepatic Portasystemic Shunt 01/2021